)

Senzime (SEZI) investor relations material
Senzime European Growth Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Key insights from presentations
Introduced a neuromuscular monitoring system, TetraGraph, enabling safer anesthesia and reducing postoperative complications through real-time, quantitative monitoring.
TetraGraph uses electromyography for high accuracy (99.7%) and has been adopted in over 4,000 operating rooms, monitoring 750,000+ patients globally.
Recent industry guidelines now recommend quantitative monitoring for all patients receiving paralytic agents, driving rapid adoption and business growth.
The company’s technology reduces drug costs by up to 70% and is especially valuable in robotic surgeries requiring deep neuromuscular blockade.
Partnerships with major firms like Fukuda Denshi and Philips expand integration and market reach, with strong traction in the U.S., Europe, and Asia.
Announcements and business performance
Achieved 90% revenue growth in the first half of the year, with sensors as the main growth driver and the U.S. accounting for 70% of business.
Installed base and recurring revenue from disposable sensors are growing at triple-digit rates, with over 700 new units delivered in Q2.
Targeting profitability by 2027 and cash flow positivity in 2026, with a focus on keeping operating expenses fixed while scaling.
Market opportunity exceeds $2 billion, with recurring revenue potential of $5,000 per monitor annually and significant room for further hospital conversions.
Backed by strong investors, including the Crawford family and major Swedish pension funds, supporting long-term global expansion.
Industry analysis and competitive positioning
Electromyography is emerging as the new gold standard in neuromuscular monitoring, replacing subjective and less accurate legacy methods.
The company leads in published studies, clinical validation, and IP portfolio (107 patents), with broad system connectivity to major hospital IT platforms.
Competitive edge comes from scientific leadership, commercial team expertise, product simplicity, and sustainability credentials.
Win rate is high in competitive evaluations, with most deals won in active markets and strong customer support throughout the adoption process.
Anticipates further growth from new pediatric guidelines and ongoing expansion in Asia and other global markets.
Next Senzime earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage